Evidence map›Paper›PMID 38155245›Full record

ArticleLeukemia2024

Loss of thymocyte competition underlies the tumor suppressive functions of the E2a transcription factor in T-ALL.

Geoffrey Parriott, Emma Hegermiller, Rosemary E Morman, Cameron Frank, Caner Saygin, Wendy Stock, Elizabeth T Bartom, Barbara L Kee

Open access · greenAbstract read
In one paragraph

Article in Leukemia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. T Cell Development: From T-Lineage Specification to Intrathymic Maturation.Advances in experimental medicine and biology · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Geoffrey ParriottCommittee on Immunology, University of Chicago, Chicago, IL, 60637, USA.
Emma HegermillerDepartment of Pathology, University of Chicago, Chicago, IL, 60637, USA.ORCID http://orcid.org/0000-0002-9835-491X
Rosemary E MormanCommittee on Immunology, University of Chicago, Chicago, IL, 60637, USA.
Cameron FrankDepartment of Pathology, University of Chicago, Chicago, IL, 60637, USA.
Caner SayginSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, 60657, USA.
Wendy StockSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, 60657, USA.
Elizabeth T BartomDepartment of Biochemistry and Molecular Genetics, Northwestern Feinberg School of Medicine, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-5618-2582
Barbara L KeeCommittee on Immunology, University of Chicago, Chicago, IL, 60637, USA. bkee@bsd.uchicago.edu.ORCID http://orcid.org/0000-0001-7014-1982
University of Chicago · USNorthwestern University · US

Funding

VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI CHIEN-MIN KAO · 1985 to 2026
$122.1M
RESEARCH TRAINING IN RESPIRATORY BIOLOGYT32HL007605 · NHLBI · UNIVERSITY OF CHICAGO · PI Yun Fang, Gokhan M. Mutlu · 1985 to 2026
$18.1M
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGYT32AI007090 · NIAID · UNIVERSITY OF CHICAGO · PI Peter Aidan Savage · 1985 to 2026
$11.7M
Mechanisms of Lymphocyte Gene Regulation by E2A and Notch1R01AI079213 · NIAID · UNIVERSITY OF CHICAGO · PI KEE, BARBARA L. · 2009 to 2010
$761k
Analysis of the role of immune deficiency in E2A-/- T cell lymphomagenesisR21AI119894 · NIAID · UNIVERSITY OF CHICAGO · PI KEE, BARBARA L. · 2015 to 2016
$419k
NCI NIH HHS P30 CA014599NHLBI NIH HHS T32 HL007605NIAID NIH HHS R01 AI079213NIAID NIH HHS R21 AI119894NIAID NIH HHS T32 AI007090
6 · The paper itself

Abstract

T lymphocyte acute lymphoblastic leukemia (T-ALL) is frequently associated with increased expression of the E protein transcription factor inhibitors TAL1 and LYL1. In mouse models, ectopic expression of TAL1 or LYL1 in T cell progenitors, or inactivation of E2A, is sufficient to predispose mice to develop T-ALL. How E2A suppresses thymocyte transformation is currently unknown. Here, we show that early deletion of E2a, prior to the DN3 stage, was required for robust leukemogenesis and was associated with alterations in thymus cellularity, T cell differentiation, and gene expression in immature CD4

Indexed as

Precursor Cell Lymphoblastic Leukemia-LymphomaPrecursor T-Cell Lymphoblastic Leukemia-LymphomaAnimalsBasic Helix-Loop-Helix ProteinsCell DifferentiationMiceThymocytesThymus GlandTranscription FactorsBasic Helix-Loop-Helix ProteinsTranscription Factors

Identifiers

PMID38155245
PMCPMC12523820
OpenAlexW4390345130

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.